BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26077033)

  • 1. Insight into response to mTOR inhibition when PKD1 and TSC2 are mutated.
    Cabrera-López C; Bullich G; Martí T; Català V; Ballarín J; Bissler JJ; Harris PC; Ars E; Torra R
    BMC Med Genet; 2015 Jun; 16():39. PubMed ID: 26077033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of TSC2/PKD1 contiguous gene deletion syndrome.
    Oyazato Y; Iijima K; Emi M; Sekine T; Kamei K; Takanashi J; Nakao H; Namai Y; Nozu K; Matsuo M
    Kobe J Med Sci; 2011 Jun; 57(1):E1-10. PubMed ID: 22169896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging features of tuberous sclerosis complex with autosomal-dominant polycystic kidney disease: a contiguous gene syndrome.
    Back SJ; Andronikou S; Kilborn T; Kaplan BS; Darge K
    Pediatr Radiol; 2015 Mar; 45(3):386-95. PubMed ID: 25355409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal Neoplasia in Polycystic Kidney Disease: An Assessment of Tuberous Sclerosis Complex-associated Renal Neoplasia and PKD1/TSC2 Contiguous Gene Deletion Syndrome.
    Gupta S; Lohse CM; Rowsey R; McCarthy MR; Shen W; Herrera-Hernandez L; Boorjian SA; Houston Thompson R; Jimenez RE; Leibovich BC; Cheville JC
    Eur Urol; 2022 Mar; 81(3):229-233. PubMed ID: 34876325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TSC2/PKD1 contiguous gene syndrome: a report of 2 cases with emphasis on dermatopathologic findings.
    Kacerovska D; Vrtel R; Michal M; Vanecek T; Vodicka R; Kreuzberg B; Ricarova R; Pizinger K; Danis D; Reischig T; Kazakov DV
    Am J Dermatopathol; 2009 Aug; 31(6):532-41. PubMed ID: 19590422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal angiomyolipoma bleeding in a patient with TSC2/PKD1 contiguous gene syndrome after 17 years of renal replacement therapy.
    Furlano M; Barreiro Y; Martí T; Facundo C; Ruiz-García C; DaSilva I; Ayasreh N; Cabrera-López C; Ballarín J; Ars E; Torra R
    Nefrologia; 2017; 37(1):87-92. PubMed ID: 27595512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal disease in adults with TSC2/PKD1 contiguous gene syndrome.
    Martignoni G; Bonetti F; Pea M; Tardanico R; Brunelli M; Eble JN
    Am J Surg Pathol; 2002 Feb; 26(2):198-205. PubMed ID: 11812941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberous sclerosis and polycystic kidney disease in a 3-month-old infant.
    Laass MW; Spiegel M; Jauch A; Hahn G; Rupprecht E; Vogelberg C; Bartsch O; Huebner A
    Pediatr Nephrol; 2004 Jun; 19(6):602-8. PubMed ID: 15007723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defects in cell polarity underlie TSC and ADPKD-associated cystogenesis.
    Bonnet CS; Aldred M; von Ruhland C; Harris R; Sandford R; Cheadle JP
    Hum Mol Genet; 2009 Jun; 18(12):2166-76. PubMed ID: 19321600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TSC2/PKD1 contiguous gene syndrome in an adult.
    Culty T; Molinie V; Lebret T; Savareux L; Souid M; Delahousse M; Botto H
    Minerva Urol Nefrol; 2006 Dec; 58(4):351-4. PubMed ID: 17268401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1/TSC2 contiguous gene syndrome.
    Consugar MB; Wong WC; Lundquist PA; Rossetti S; Kubly VJ; Walker DL; Rangel LJ; Aspinwall R; Niaudet WP; Ozen S; David A; Velinov M; Bergstralh EJ; Bae KT; Chapman AB; Guay-Woodford LM; Grantham JJ; Torres VE; Sampson JR; Dawson BD; Harris PC;
    Kidney Int; 2008 Dec; 74(11):1468-79. PubMed ID: 18818683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent Reduced Expression of Contiguous
    Meguro S; Koguchi T; Hakozaki Y; Onagi A; Matsuoka K; Hoshi S; Hata J; Sato Y; Akaihata H; Kataoka M; Ogawa S; Kojima Y
    Cancer Genomics Proteomics; 2023; 20(1):40-50. PubMed ID: 36581342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tuberous sclerosis proteins regulate formation of the primary cilium via a rapamycin-insensitive and polycystin 1-independent pathway.
    Hartman TR; Liu D; Zilfou JT; Robb V; Morrison T; Watnick T; Henske EP
    Hum Mol Genet; 2009 Jan; 18(1):151-63. PubMed ID: 18845692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two novel gross deletions of TSC2 in Malaysian patients with tuberous sclerosis complex and TSC2/PKD1 contiguous deletion syndrome.
    Ismail NF; Nik Abdul Malik NM; Mohseni J; Rani AM; Hayati F; Salmi AR; Narazah MY; Zabidi-Hussin ZA; Silawati AR; Keng WT; Ngu LH; Sasongko TH
    Jpn J Clin Oncol; 2014 May; 44(5):506-11. PubMed ID: 24683199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboxy terminal tail of polycystin-1 regulates localization of TSC2 to repress mTOR.
    Dere R; Wilson PD; Sandford RN; Walker CL
    PLoS One; 2010 Feb; 5(2):e9239. PubMed ID: 20169078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease--a contiguous gene syndrome.
    Brook-Carter PT; Peral B; Ward CJ; Thompson P; Hughes J; Maheshwar MM; Nellist M; Gamble V; Harris PC; Sampson JR
    Nat Genet; 1994 Dec; 8(4):328-32. PubMed ID: 7894481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gross genomic rearrangement involving the TSC2-PKD1 contiguous deletion syndrome: characterization of the deletion event by quantitative polymerase chain reaction deletion assay.
    Boehm D; Bacher J; Neumann HP
    Am J Kidney Dis; 2007 Jan; 49(1):e11-21. PubMed ID: 17185137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene.
    Sampson JR; Maheshwar MM; Aspinwall R; Thompson P; Cheadle JP; Ravine D; Roy S; Haan E; Bernstein J; Harris PC
    Am J Hum Genet; 1997 Oct; 61(4):843-51. PubMed ID: 9382094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TSC2/PKD1 contiguous gene syndrome, with emphasis on a case with an atypical mild polycystic kidney phenotype and a novel genetic variant.
    Reyna-Fabián ME; Alcántara-Ortigoza MA; Hernández-Martínez NL; Berumen J; Jiménez-García R; Gómez-Garza G; González-Del Angel A
    Nefrologia (Engl Ed); 2020; 40(1):91-98. PubMed ID: 31176519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells.
    de Stephanis L; Bonon A; Varani K; Lanza G; Gafà R; Pinton P; Pema M; Somlo S; Boletta A; Aguiari G
    Clin Exp Nephrol; 2017 Apr; 21(2):203-211. PubMed ID: 27278932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.